spacer
home > epc > summer 2002 > making the right choice in pharmaceutical outsourcing
PUBLICATIONS
European Pharmaceutical Contractor

Making the Right Choice in Pharmaceutical Outsourcing

Outsourcing of analysis within the pharmaceutical industry has steadily increased in recent years and this trend seems set to continue with estimated growth being as high as 9 per cent per annum.

Key reasons for outsourcing analysis include:

Little or no facilities in-house

Utilisation of internal competence on higher value return science, such
as better value for money from internal staff

In-house capacity problems due to increased testing in line with regulations

The problem of choosing the right outsourcing partner has been exacerbated by the growth in the number of contract service organisations (CSOs) on the market. Often these organisations appear to offer similar services and returns for the customer - thus making the partnering decision difficult.

This article will explore four key areas worthy of consideration when selecting your outsourcing laboratory.

Balancing Cost and Confidence

When faced with the prospect of outsourcing you must be convinced of the viability and robustness of your decision to hand over control of a project to a third party. As the project manager, you must be confident about getting value for money, quality and delivery from your outsourcing partner.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Brian Arnot, Business Development Executive at Tepnel Scientific Services

Brian Arnot is an experienced Analytical Chemist who has worked in the contract analytical services sector since 1984.

More recently, he has joined the business development team of Tepnel Scientific Services (formerly the Medicines Testing Laboratory), where he is responsible for the development of core business activities in both the UK and Europe.

spacer
Brian Arnot
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TrialScope Announces Partnership with Greater Gift

JERSEY CITY, NJ – May 14, 2019 – TrialScope, the global leader in clinical trial transparency, disclosure compliance and patient engagement solutions, has partnered with Greater Gift to donate vaccines to children in need.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement